![Mark Collins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Collins
Director/Board Member at
LUNAI BIOWORKS INC.
Net worth: 18 748 $ as of 2026-09-29
Profile
Dr. Mark A. Collins is an Independent Director at Lunai Bioworks, Inc. and a Chief Scientific Officer at Undaunted Bio, Inc. He is on the Board of Directors at Lunai Bioworks, Inc. Dr. Collins was previously employed as a Chief Technology Officer by Helomics Corp.
and a Vice President-Translational Service by icometrix NV.
He received his undergraduate degree from the University of Wolverhampton and a doctorate degree from the University of Surrey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LUNAI BIOWORKS, INC. 0.25% | 2026-10-12 | 12,754 ( 0.25% ) | 18 748 $ | 2026-09-29 |
Mark Collins active positions
| Companies | Position | Start |
|---|---|---|
| LUNAI BIOWORKS INC. | Director/Board Member | 2024-10-13 |
Former positions of Mark Collins
| Companies | Position | End |
|---|---|---|
Helomics Corp.
 Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Chief Tech/Sci/R&D Officer | 2020-12-31 |
icometrix NV
 icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Corporate Officer/Principal | 2020-12-31 |
Education of Mark Collins
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Helomics Corp.
Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Commercial Services |
University of Wolverhampton
 University of Wolverhampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
icometrix NV
icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Technology Services |
- Stock Market
- Insiders
- Mark Collins
